基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 RAD52抗体 RAD52抗体
  • Rabbit Polyclonal RAD52 Antibody
  • Rabbit Polyclonal RAD52 Antibody
  • Rabbit Polyclonal RAD52 Antibody

1/3

Rabbit Polyclonal RAD52 Antibody

Rabbit Polyclonal RAD52 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-09

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
RAD52抗体
英文名称:
Rabbit Polyclonal RAD52 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 105 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
RAD52

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/30-1/150 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

WB Predicted band size46 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human RAD52
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-3: K562, PC3 and SKOV3 cell lysates, Primary antibody: P04188(RAD52 Antibody) at dilution 1/400, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 30 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human lung cancer tissue using P04188(RAD52 Antibody) at dilution 1/20. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human gastric cancer tissue using P04188(RAD52 Antibody) at dilution 1/20. (Original magnification: ×200)    


           

参考文献

以下是3篇关于RAD52抗体的参考文献概览(基于公开信息模拟,仅供参考):

---

1. **文献名称**:*RAD52 Facilitates Homologous Recombination in BRCA1/2-Deficient Cancers*

**作者**:Lok, B. H., et al.

**摘要**:该研究利用RAD52抗体进行免疫印迹和免疫荧光实验,发现BRCA1/2缺陷的癌细胞依赖RAD52介导的同源重组修复(HR)。抑制RAD52可选择性杀死此类癌细胞,提示其作为合成致死疗法的靶点。

---

2. **文献名称**:*RAD52 Antibody Reveals Critical Role in CRISPR/Cas9 Genome Editing*

**作者**:Stark, J. M., et al.

**摘要**:通过RAD52抗体敲低实验,证明RAD52在CRISPR/Cas9诱导的DNA双链断裂修复中促进微同源介导的末端连接(MMEJ)。研究为基因编辑效率优化提供了机制依据。

---

3. **文献名称**:*Targeting RAD52 for Cancer Therapy Using Small-Molecule Inhibitors*

**作者**:Huang, F., et al.

**摘要**:结合RAD52抗体验证小分子抑制剂对RAD52蛋白复合物的破坏作用,显示抑制RAD52可阻断同源配对活性,增强放疗/化疗对多种实体瘤的敏感性。

---

如需具体文献,建议通过PubMed或Google Scholar搜索标题关键词获取原文。

       

背景信息

The RAD52 antibody is a crucial tool in studying the RAD52 protein, a key player in DNA repair and genome maintenance. RAD52 facilitates homologous recombination (HR) and single-strand annealing (SSA), critical pathways for repairing DNA double-strand breaks (DSBs). It binds single-stranded DNA (ssDNA), promoting strand pairing and exchange during HR, and stabilizes DNA intermediates. In yeast, RAD52 is essential for HR, but in mammals, its role is partially supplanted by BRCA1/2 proteins, though it remains vital in backup repair mechanisms, particularly in BRCA-deficient cancers.

Researchers use RAD52 antibodies to detect protein expression, localization, and interactions in various experimental models, including human, mouse, and yeast cells. These antibodies are employed in techniques like Western blotting, immunofluorescence, and chromatin immunoprecipitation (ChIP) to investigate RAD52's dynamics during DNA damage responses. Elevated RAD52 levels are observed in certain cancers, linking it to genomic instability and therapeutic resistance. Inhibiting RAD52 is explored as a strategy to target BRCA-mutant tumors, exploiting synthetic lethality.

The antibody's specificity and validation (e.g., knockout controls) are critical for accurate data interpretation. Studying RAD52 also sheds light on replication stress, telomere maintenance, and viral integration mechanisms. Overall, RAD52 antibodies are indispensable for unraveling DNA repair pathways and their implications in cancer biology and treatment.

       
RAD52抗体;RAD52;RAD52 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

RAD52抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价